Statistics
Total Visits
Views | |
---|---|
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase | 92 |
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase | 71 |
Total Visits per Month
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
---|---|---|---|---|---|---|---|
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase | 2 | 3 | 1 | 2 | 2 | 11 | 10 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 64 |
China | 17 |
Australia | 11 |
Singapore | 9 |
Netherlands | 8 |
Vietnam | 5 |
Germany | 2 |
France | 2 |
Argentina | 1 |
Colombia | 1 |
Top City Views
Views | |
---|---|
Ashburn | 19 |
Fairfield | 8 |
Rotterdam | 8 |
Cambridge | 6 |
Zhengzhou | 6 |
Hanoi | 5 |
Kaleen | 5 |
Singapore | 5 |
Tustin | 4 |
Beijing | 3 |